Miglitol 25 mg Australia

Description

Introduction

Miglitol 25 mg Australia is a tablet containing 25 mg of the active ingredient miglitol. Miglitol is used to help manage blood glucose in type 2 diabetes. Its main effect is on the rise in blood glucose after a meal, when carbohydrates are digested and absorbed.

Diabetes care also involves food choices, physical activity and blood glucose monitoring. A healthcare professional can assess whether miglitol fits an individual treatment plan.

What Is It?

Miglitol belongs to a group of medicines called alpha-glucosidase inhibitors. These medicines act in the small intestine, where enzymes break down carbohydrates into sugars that can be absorbed. This product is presented as a 25 mg tablet for oral use.

The inactive ingredients of this particular tablet are not confirmed here. Anyone who needs to check an ingredient because of an allergy or intolerance should ask a pharmacist for product-specific information.

How Does It Work?

Miglitol slows the breakdown of table sugar and complex carbohydrates in the small intestine. Glucose from a meal is consequently absorbed more gradually, which can reduce the rise in blood glucose after eating.

Miglitol does not replace insulin. Its effect relates to carbohydrate digestion, so it remains part of a broader diabetes care plan. Blood glucose results help a healthcare professional assess the response to treatment over time.

Common Uses

Miglitol is used alongside diet and exercise to improve blood glucose control in type 2 diabetes. It may be prescribed alone or with another diabetes medicine. The choice depends on medical history, glucose results, other medicines and treatment goals.

Miglitol is not a treatment for diabetic ketoacidosis. Ask a healthcare professional about any other proposed use rather than assuming it is appropriate.

Available Strengths

This family is available in 25 mg, 50 mg.

Key Features

• Contains 25 mg of miglitol per tablet.
• Tablet formulation intended for oral use.
• Acts on carbohydrate digestion in the small intestine.
• Has its main glucose-lowering effect after meals.
• May form one part of a type 2 diabetes treatment plan.

Benefits

• Clinical studies of miglitol have shown reductions in post-meal blood glucose compared with placebo.
• Miglitol has also improved measures of longer-term blood glucose control in clinical studies.
• Its action differs from that of medicines that increase insulin release.
• It can be considered alongside other diabetes treatments when a prescriber judges the combination appropriate.

These findings do not predict an individual response. A reduction in the risk of heart attack, stroke or other major blood vessel outcomes has not been conclusively established for miglitol.

Possible Side Effects

• Wind, abdominal discomfort, soft stools and diarrhoea are commonly reported, particularly during the first weeks of treatment.
• These digestive effects may lessen over time, although persistent or troublesome symptoms should be discussed with a healthcare professional.
• A skin rash can occur. Seek medical advice if a rash develops.
• Low blood glucose can occur when miglitol is combined with insulin or a sulfonylurea.
• Possible signs of low blood glucose include shakiness, sweating, hunger, dizziness and confusion. Severe symptoms, such as seizures or loss of consciousness, need urgent medical attention.

This is not a complete list of possible side effects. A pharmacist or prescriber can provide guidance about symptoms that cause concern.

Precautions

• Miglitol should not be used by someone with a known allergy to miglitol or another ingredient in the tablet.
• It is contraindicated in diabetic ketoacidosis.
• Inflammatory bowel disease, colonic ulceration, partial intestinal obstruction and certain chronic intestinal conditions are contraindications.
• Kidney impairment should be discussed with a prescriber. Miglitol exposure rises as kidney function declines, and information about long-term use in significant kidney impairment is limited.
• Pregnancy, plans for pregnancy and breastfeeding should be discussed with a healthcare professional before treatment.

Additional Precautions

• Continue the blood glucose monitoring plan recommended by the diabetes care team, especially when treatment or other medicines change.
• Missed meals, changes in physical activity and alcohol can affect blood glucose. A healthcare professional can explain how these factors apply to a treatment plan.
• Using miglitol with insulin or a sulfonylurea can increase the risk of low blood glucose. The combination may require closer monitoring.
• Miglitol slows the breakdown of table sugar. Glucose, also called dextrose, is preferred to table sugar for treating mild to moderate low blood glucose during treatment. Ask a healthcare professional for an appropriate response plan.
• Keep an up-to-date list of medicines and supplements for medical and pharmacy appointments.

Storage Instructions

• Keep tablets in their original, tightly closed packaging.
• Store at room temperature, away from excess heat and moisture.
• Keep all medicines out of sight and reach of children.
• Check the supplied packaging for the expiry date and any product-specific storage directions.
• Ask a pharmacist how to dispose of tablets that are expired or no longer needed.

How to Take

• Miglitol tablets are taken by mouth with a meal. Follow the timing and directions on the prescription label.
• A prescriber determines the dose and any changes using blood glucose results, tolerability and other clinical information.
• Do not change the prescribed schedule without professional guidance.
• If a dose or meal is missed, follow the prescription directions or ask a pharmacist what to do. Do not take a double dose to make up for a missed one.
• Continue the food, activity and monitoring plan agreed with the diabetes care team.

Drug Interactions

• Insulin and sulfonylureas can increase the risk of low blood glucose when combined with miglitol.
• Intestinal adsorbents, such as activated charcoal, and digestive enzyme preparations containing carbohydrate-splitting enzymes may reduce miglitol’s effect.
• Miglitol has affected the absorption of some other medicines in studies. A pharmacist can review the full medicine list for relevant interactions.
• Tell a healthcare professional about prescription medicines, over-the-counter products, vitamins and supplements before starting or changing treatment.

Why Choose This Product?

• The tablet provides a stated 25 mg amount of miglitol for consideration within a prescribed treatment plan.
• Miglitol has a documented effect on post-meal blood glucose through its action in the small intestine.
• Its tablet form provides an oral treatment option when a healthcare professional considers miglitol appropriate.

Suitability depends on medical history, other medicines and treatment goals. Ask a healthcare professional for product-specific guidance.

Frequently Asked Questions (FAQs)

What is the active ingredient?

The active ingredient is miglitol. The stated strength is 25 mg per tablet.

Is miglitol an insulin product?

No. Miglitol is an alpha-glucosidase inhibitor that slows carbohydrate digestion in the small intestine.

What condition is miglitol used for?

It is used to help improve blood glucose control in type 2 diabetes alongside diet and exercise.

Does it work mainly after meals?

Yes. Its main effect is to reduce the rise in blood glucose after eating.

Can it cause low blood glucose?

The risk increases when miglitol is taken with insulin or a sulfonylurea. A diabetes care team can explain how to recognise and respond to it.

What are the most common side effects?

Wind, diarrhoea, soft stools and abdominal discomfort are among the commonly reported effects.

Can someone with bowel disease use miglitol?

Some bowel conditions are contraindications. A prescriber should review the diagnosis before treatment.

What if a dose is missed?

Follow the prescription directions or ask a pharmacist. Do not take a double dose to make up for a missed one.

How should the tablets be stored?

Keep them in their original packaging at room temperature, away from excess heat and moisture, and out of children’s reach.

Related Products

• Miglitol 25 mg Australia
• Miglitol 50 mg Australia
• Repaglinide 2 mg Australia
• Bromocriptine 2.5 mg Australia
• Glimepiride 1 mg Australia
• Acarbose 25 mg Australia